Inhibition of miR‐21 alleviated cardiac perivascular fibrosis via repressing EndMT in T1DM

Author:

Li Qianqian1ORCID,Yao Yufeng1,Shi Shumei1,Zhou Mengchen1,Zhou Yingchao1,Wang Mengru1,Chiu Jeng‐Jiann2,Huang Zhengrong3,Zhang Weili4ORCID,Liu Min5,Wang Qing167,Tu Xin1

Affiliation:

1. Key Laboratory of Molecular Biophysics of the Ministry of Education College of Life Science and Technology and Center for Human Genome Research Huazhong University of Science and Technology Wuhan China

2. Institute of Cellular and System Medicine National Health Research Institutes Miaoli Taiwan

3. Department of Cardiology The First Affiliated Hospital of Xiamen University Xiamen China

4. State Key Laboratory of Cardiovascular Disease Hypertension Center FuWai Hospital National Center for Cardiovascular Diseases Chinese Academy of Medical Sciences (CAMS) & Peking Union Medical College (PUMC) Beijing China

5. Hypertension Department of Henan Provincial People's Hospital Henan China

6. Center for Cardiovascular Genetics Department of Molecular Cardiology Cleveland Clinic Cleveland OH USA

7. Department of Genetics and Genome Sciences Case Western Reserve University Cleveland OH USA

Funder

National Natural Science Foundation of China

Publisher

Wiley

Subject

Cell Biology,Molecular Medicine

Cited by 48 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3